AACR Virtual Patient Advocate Forum: COVID-19 and Cancer
October 1, 2020
The COVID-19 pandemic has sickened more than 22.8 million people globally and claimed the lives of more than 796,000 people around the world. It threatens to reverse decades of research progress in the fight against cancer and jeopardize the future care and treatment of patients with cancer. AACR is working diligently to keep all members of the cancer community informed and safe from infection. Advocates from across the cancer community joined this free virtual event to get the latest information on COVID-19 and cancer.
Moderated by Anna D. Barker, PhD, Chief Strategy Officer of the Ellison Institute for Transformative Medicine, USC and co-founder of the AACR Scientist↔Survivor Program®, the program featured:
- Patient perspectives on the impact on cancer care and research
- Current state of COVID-19 science
- Development of COVID-19 treatments and vaccines
- Impact on healthcare for patients with cancer
Follow or join the conversation on social media with the hashtag #AACRCOVID.
The AACR Patient Advocate Program sends monthly emails highlighting opportunities to apply for educational and training programs, announcements for workshops and conferences, congressional briefings and legislative updates, and articles about advocacy, patient engagement, and cancer survivorship.